All Type of News
Japanese talc conforms to KFDA’s talc standards
The Korea Testing and Research Institute for Chemical Industry said that the dissolution test results of 24 tons of Japanese talc that had passed through customs on April 1 are in conformity with the current standards...
Korea Biotechnology Industry Association changes its name to Korea Bio Venture Association
Korea Biotechnology Industry Association changes its name to Korea Bio Venture Association
Rep. Bae Eun-hee of the ruling Grand National Party said in a forum that the name of Korea Biotechnology Industry Associat...
Bayer HealthCare’s Xarelto approved in Korea
Bayer HealthCare’s Xarelto approved in Korea
The Korea Food and Drug Administration granted on April 13 Bayer HealthCare marketing authorization for the anticoagulant Xarelto (rivaroxaban), taken as one tablet, onc...
Dong-A, Asahi Kasei join forces over Flivas
Dong-A Pharmaceutical announced on April 15 that it has entered into an exclusive license agreement Asahi Kasei Pharma in Japan, granting Dong-A to develop and sales of naftopidil, an agent for the treatment of benign...
Recall measure seen to be hasty, less feasible
The Korea Food and Drug Administration (KFDA)’s sales ban was far from being feasible since it has not confirmed whether asbestos was really detected and on top of that, the KFDA measure was based on a supplement list...
KFDA to face damage suit from pharmaceutical companies
Members of the Korea Pharmaceutical Manufacturers Association said 14 that it would file a joint suit against the Korea Food and Drug Administration for having hastily banned sales of drugs without a thorough investig...
Intractable diseases strike 500,000 Korean people
The number of patients with intractable diseases is estimated to be 500,000, according to a lawmaker.
“The government should work out measures to lower the price of orphan drugs,” Rep. Jeon Hyun-hee said in a recen...
Hanmi releases smoking cessation treatment
Hanmi Pharm says it has launched a sustained release formulation of bupropion HCl 150 mg as a smoking cessation aid, intended to be taken once a day.
Originally marketed as an anti-depressant drug, bupropion is ava...
Hyundai Pharm launches once-daily escitalopram formulation
Hyundai Pharm said on April 15 it launched an once-daily oral escitalopram tablet, aiming to boost sales in the local market.
The company is seeking to expand its presence in the local antidepressant medication mar...
Drug agency to look into foreign drug makers
The nation's food and drug watchdog is considering embarking on looking into the discovery of asbestos-containing talc in medicines produced by foreign-invested pharmaceutical firms.
During the session of the parli...
